In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

AstraZeneca PLC Balance Sheet Statement - Assets

As of 31 Dec 2022, The total current assets of AstraZeneca PLC (LSE:AZN) was around $22,593,000,000 which consisted of $6,166,000,000 of Cash, $4,699,000,000 of Inventory and $9,923,000,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in USD

Current assets
Total assets

The latest balance sheet of AstraZeneca PLC also showed $9,449,000,000 of Property Plant Equipment and $19,820,000,000 of Good will. Also there were $39,307,000,000 of Intangible assets and $4,172,000,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $96,483,000,000.

AstraZeneca PLC Balance Sheet Statement - Liabilities

AZN's latest annual results shows the balance sheet has $2,550,000,000 of Accounts Payable. Also there were $960,000,000 of Short/Long term debt, $23,908,000,000 of Long term debt, $3,814,000,000 of Other Current liabilities and $26,293,000,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
Current liabilities
Total liabilities

As per the 31 Dec 2022's annual report of AstraZeneca PLC, the total liabilities were $59,425,000,000.

AZN Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of AstraZeneca PLC showed the total stock holder equity was $37,037,000,000 which consisted of $387,000,000 of Common stocks, $3,120,000,000 of Retained earnings and $-1,625,000,000 of Other stock holder equity.

AZN Balance Sheet Statement History

Following table shows the history of balance sheet for AstraZeneca PLC (AZN).

31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Cash 6.17B 6.33B 7.83B 5.37B
Net Receivables 9.92B 8.79B 5.65B 5.18B
Inventory 4.7B 8.98B 4.02B 3.19B
Total Current Assets 22.59B 26.24B 19.54B 15.56B
Property Plant Equipment 9.45B 10.17B 8.92B 8.34B
Good Will 19.82B 20B 11.85B 11.67B
Intangible Assets 39.31B 42.39B 20.95B 20.83B
Other Assets 4.17B 5.3B 4.28B 3.47B
Deferred Long Term Asset Charges 3.26B 4.33B 3.44B 2.72B
Total Assets 96.48B 105.36B 66.73B 61.38B
Accounts Payable 2.55B 2.82B 2.35B 1.77B
Short/Long Term Debt 960M 2.25B 1.57B 1.63B
Other Current Liabilities 3.81B 4.52B 5.85B 4.9B
Long Term Debt 23.91B 29.72B 19.8B 17.89B
Other Liabilities 8.5B 13.01B 10.49B 10.28B
Total Current Liabilities 26.29B 22.59B 20.31B 18.12B
Total Liabilities 59.42B 66.08B 51.09B 46.78B
Common Stock 387M 387M 328M 328M
Retained Earnings 3.12B 3.64B 6.44B 5B
Treasury Stock -1.62B 111M 881M -143M
Other Stockholder Equity -1.62B 111M 881M -143M
Total Stockholder Equity 37.04B 39.27B 15.62B 13.13B
Net Tangible Assets -22.09B -23.12B -17.17B -19.37B

AstraZeneca PLC (LSE:AZN) Balance Sheet Statement FAQ

1. How much Cash AstraZeneca PLC has on their balance sheet?

As of 31 Dec 2022, AstraZeneca PLC (LSE:AZN) has $6,166,000,000 of Cash.

2. What's the long term debt of AstraZeneca PLC?

As per the latest Balance sheet of AstraZeneca PLC (LSE:AZN), it has $23,908,000,000 of Long term debt.

3. How much share holder equity does AstraZeneca PLC has?

The AstraZeneca PLC (LSE:AZN)'s balance sheet shows that it has $37,037,000,000 of Total stock holder equity.